Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of bupropion and varenicline in the treatment of nicotine use disorder
IRCT20210608051514N4Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of bupropion and varenicline in nicotine dependence (2 arms), sponsored by Iran University of Medical Sciences. Started Jan 2025; status: completed.
02
Drugs
bupropionvarenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on IRCT20210608051514N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210608051514N4.